23 results
424B3
KZIA
Kazia Therapeutics Limited
19 Apr 24
Prospectus supplement
4:30pm
to causes beyond its reasonable control, including but not limited to acts of God, epidemic or pandemic, natural disaster, labor disturbances, terrorist
6-K
EX-10.1
KZIA
Kazia Therapeutics Limited
19 Apr 24
Current report (foreign)
4:26pm
reasonable control, including but not limited to acts of God, epidemic or pandemic, natural disaster, labor disturbances, terrorist attack, riots or wars
424B5
KZIA
Kazia Therapeutics Limited
4 Dec 23
Prospectus supplement for primary offering
4:05pm
filings;
expectations about approval by regulatory authorities of our drug candidates;
the impact that the COVID-19 pandemic could have on our
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
5 Sep 23
Current report (foreign)
7:02am
, and conflicts and other events of geopolitical significance, such as the COVID-19 pandemic and the conflict between Russia and Ukraine, could … , which has been significantly impacted by the ongoing COVID19 pandemic and geopolitical instability due to the ongoing military conflict between
6-K
EX-99.1
kndqrtnx6elics azn
1 Sep 22
Current report (foreign)
4:07pm
6-K
y1yl2cig2lal
30 Jun 22
Current report (foreign)
6:04am
424B5
ybhm3q65 1ry
22 Apr 22
Prospectus supplement for primary offering
4:04pm
6-K
rinn dramd1r
24 Mar 22
Current report (foreign)
6:06am
6-K
y66 q18r7o
10 Nov 21
Current report (foreign)
6:04am
F-3
eb3sz
1 Sep 21
Shelf registration (foreign)
7:25am
424B5
s24kh66p8wh8yr53
31 Mar 21
Prospectus supplement for primary offering
6:30am
6-K
699y0 sjlydzlall3qbg
24 Mar 21
Current report (foreign)
6:13am
6-K
oqfiz4xywr7 xg
6 Nov 20
Current report (foreign)
6:04am